Summaries for patients. Targeting cholesterol treatment toward increasing high-density lipoprotein levels.
D000368:Aged; D008076:Cholesterol, HDL / Q000378:metabolism*; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use; D017023:Coronary Angiography; D003327:Coronary Disease / Q000097:blood* / Q000178:diet therapy / Q000628:therapy*; D018450:Disease Progression; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005081:Exercise Therapy; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000009:adverse effects / Q000627:therapeutic use
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D002792:Cholestyramine Resin; D009525:Niacin; D015248:Gemfibrozil